Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer

被引:24
作者
Ceylan, Cemile [1 ]
Kucuk, Nadir [1 ]
Ayata, Hande Bas [1 ]
Guden, Metin [1 ]
Engin, Kayihan [1 ]
机构
[1] Anadolu Med Ctr, Radiat Oncol, Anadolu Caddesi,1 Gebze, TR-41400 Kocaeli, Turkey
关键词
Prostate; IMRT; CyberKnife; Radiosurgery;
D O I
10.1016/j.rpor.2010.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of our study was the dosimetric and physical evaluation of the CK and IMRT treatment plans for 16 patients with localized prostate cancer. Background: Intensity modulated radiation therapy (IMRT) is one of the recent technical advances in radiotherapy. The prostate is a well suited site to be treated with IMRT. The challenge of accurately delivering the IMRT needs to be supported by new advances such as image-guidance and four-dimensional computed conformal radiation therapy (4DCRT) tomography. CyberKnife (CK) provides real time orthogonal X-ray imaging of the patient during treatment course to follow gold fiducials installed into the prostate and to achieve motion correlation between online acquired X-ray imaging and digital reconstructed radiographs (DRRs) which are obtained from planning computed tomography images by translating and rotating the treatment table in five directions. Methods and materials: Sixteen IMRT and CK plans were performed to be compared in terms of conformity (CI), heterogeneity indices (HI), percentage doses of 100% (V100), 66% (V66), 50% (V50), 33% (V33) and 10% (V10) volumes of the bladder and rectum. Dose-volume histograms for target and critical organs, (CI) and indices (HI) and isodose lines were analyzed to evaluate the treatment plans. Results: Statistically significant differences in the percentage rectal doses delivered to V10, V33, and V50 of the rectum were detected in favor of the CK plans (p values; < 0.001, < 0.001 and 0.019, respectively). The percentage doses for V66 and V100 of the rectum were larger in CK plans (13%, 2% in IMRT and 21%, 3% in CK plans, respectively). Percentage bladder doses for V10 and V33 were significantly lower in CK plans [96% in IMRT vs 48% in CK (p < 0.001) and 34% in IMRT vs 24% in CK (p = 0.047)]. Lower percentage doses were observed for V50, V66 of the bladder for the IMRT. They were 5.4% and 3.45% for IMRT and 13.4% and 8.05% for CK, respectively. Median CI of planning target volume (PTV) for IMRT and CK plans were 0.94 and 1.23, respectively (p < 0.001). Conclusion: Both systems have a very good ability to create highly conformal volumetric dose distributions. Median HI of PTV for IMRT and CK plans were 1.08 and 1.33, respectively (p < 0.001). (C) 2010 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 30 条
[1]   Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement [J].
Adams, EJ ;
Convery, DJ ;
Cosgrove, VP ;
McNair, HA ;
Staffurth, JN ;
Vaarkamp, J ;
Nutting, CM ;
Warrington, AP ;
Webb, S ;
Balyckyi, J ;
Dearnaley, DP .
RADIOTHERAPY AND ONCOLOGY, 2004, 70 (01) :1-10
[2]   Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy [J].
Ashman, JB ;
Zelefsky, MJ ;
Hunt, MS ;
Leibel, SA ;
Fuks, Z .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :765-771
[3]  
Aubin M, 2002, 44 ANN ASTRO M
[4]   Guidelines for primary radiotherapy of patients with prostate cancer [J].
Boehmer, Dirk ;
Maingon, Philippe ;
Poortmans, Philip ;
Baron, Marie-Helene ;
Miralbell, Raymond ;
Remouchamps, Vincent ;
Scrase, Christopher ;
Bossi, Alberto ;
Bolla, Michel .
RADIOTHERAPY AND ONCOLOGY, 2006, 79 (03) :259-269
[5]   Hypofractionation for prostate cancer radiotherapy - What are the issues? [J].
Brenner, DJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :912-914
[6]   Fractionation and protraction for radiotherapy of prostate carcinoma [J].
Brenner, DJ ;
Hall, EJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05) :1095-1101
[7]   Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond [J].
Bucci, MK ;
Bevan, A ;
Roach, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :117-134
[8]  
Cavedon Carlo, 2005, ROBOTIC RADIOSURGERY, V1, P81
[9]   Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients [J].
De Meerleer, G ;
Vakaet, L ;
Meersschout, S ;
Villeirs, G ;
Verbaeys, A ;
Oosterlinck, W ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03) :777-787
[10]   Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison [J].
De Meerleer, GO ;
Vakaet, LAML ;
De Gersem, WRT ;
De Wagter, C ;
De Naeyer, B ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03) :639-648